Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD> Source: Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more Year: 2020
Bronchiectasis and airway eosinophilia in severe asthma—is there an association? Source: Virtual Congress 2020 – Phenotypes of obstructive diseases Year: 2020
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Eosinophilic airway inflammation in COPD and asthma Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008
Role of tissue kallikrein 1 in late phase bronchoconstriction and airway hyperresponsiveness Source: Annual Congress 2006 - Basic mechanisms of allergic airways inflammation Year: 2006
Treating children with airway malacia, a role for asthma medication? Source: Annual Congress 2013 –Airway malacia in wheezy infants and pre-school children, or is it asthma? Year: 2013
Smoking effect on airways inflammation in asthma and COPD: relationship with airways reversibility and hyperresponsiveness Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009
The crucial role of airway nerves in asthma and COPD Source: Annual Congress 2012 - ERS Romain Pauwels Research Award Ceremony (supported by GlaxoSmithKline) followed by the Hot Topic "The nerves are back!" Year: 2012
Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014
Heterogeneous response of airway eosinophilia to biologics in severe asthma patients Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies Year: 2021
The influence of obesity on bronchial hyperresponsiveness, airway and systemic inflammation, lung function and quality of life in patients with asthma Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
Induced sputum and airway inflammation in asthma and COPD Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006
The role of response to bronchodilators in differential diagnosis of COPD and asthma Source: Eur Respir J 2003; 22: Suppl. 45, 424s Year: 2003
Factors driving airway eosinophilia in prednisone-dependent severe asthma Source: International Congress 2017 – Pathophysiology and emerging therapies for severe asthma Year: 2017
Does a correlation exist between bronchial hyperresponsiveness and therapy in asthma? Source: Eur Respir J 2002; 20: Suppl. 38, 49s Year: 2002
Is atopy an important factor of bronchial hyperresponsiveness in asthmatic patients? Source: Eur Respir J 2001; 18: Suppl. 33, 368s Year: 2001
Neuroregulatorial therapy of bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 55s Year: 2002
Small airways disease and peripheral eosinophilia predict airway hyperresponsiveness in Irish patients with suspected asthma Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015
F eNO -based asthma management results in faster improvement of airway hyperresponsivenessSource: ERJ Open Res, 4 (4) 00147-2017; 10.1183/23120541.00147-2017 Year: 2018
The clinical importance of small airway involvement in patients with asthma and COPD Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD Year: 2019